
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Myeloid-Derived Suppressor Cells and Radiotherapy
Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 545-557
Open Access | Times Cited: 58
Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 545-557
Open Access | Times Cited: 58
Showing 26-50 of 58 citing articles:
Unlocking the Radiosensitizing Potential of MYC inhibition in Neuroendocrine Malignancies
Qianyu Guo, William Yang, Guy Robinson, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Open Access
Qianyu Guo, William Yang, Guy Robinson, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Open Access
Radiation-induced amphiregulin drives tumour metastasis
András Piffkó, Kaiting Yang, Arpit Panda, et al.
Nature (2025)
Closed Access
András Piffkó, Kaiting Yang, Arpit Panda, et al.
Nature (2025)
Closed Access
Recent advances in regulatory immune cells: exploring the world beyond Tregs
Peng Shi, Yi Yu, Hongwei Xie, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Peng Shi, Yi Yu, Hongwei Xie, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations
Ryan McMahon, Criselle D’Souza, Paul J. Neeson, et al.
Neoplasia (2023) Vol. 46, pp. 100940-100940
Open Access | Times Cited: 9
Ryan McMahon, Criselle D’Souza, Paul J. Neeson, et al.
Neoplasia (2023) Vol. 46, pp. 100940-100940
Open Access | Times Cited: 9
Mechanistic rationales for combining immunotherapy with radiotherapy
Alexander Chi, Nam P. Nguyen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Alexander Chi, Nam P. Nguyen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos‐Hoff, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos‐Hoff, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
Mohammad A. Al-Mterin, Eyad Elkord
Exploration of Targeted Anti-tumor Therapy (2022), pp. 497-510
Open Access | Times Cited: 12
Mohammad A. Al-Mterin, Eyad Elkord
Exploration of Targeted Anti-tumor Therapy (2022), pp. 497-510
Open Access | Times Cited: 12
A critical review on exploring tumor Microenvironment's impacts on radioresistance
Mohammad Houshyari
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100937-100937
Open Access | Times Cited: 2
Mohammad Houshyari
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100937-100937
Open Access | Times Cited: 2
Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma
Shoma Yamamoto, Minoru Kato, Yuji Takeyama, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 12, pp. 2197-2205
Open Access | Times Cited: 6
Shoma Yamamoto, Minoru Kato, Yuji Takeyama, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 12, pp. 2197-2205
Open Access | Times Cited: 6
Photothermal properties of PLGA/graphene composite nanofiber membrane for potential anti-tumor application
Yijun Fu, Chi Chen, Chaowei Li, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134628-134628
Closed Access | Times Cited: 9
Yijun Fu, Chi Chen, Chaowei Li, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134628-134628
Closed Access | Times Cited: 9
Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression
Viktoria Plackoska, Dania Shaban, Anastasia Nijnik
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Viktoria Plackoska, Dania Shaban, Anastasia Nijnik
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model
Qianling Jiang, Jielin Duan, Luc Van Kaer, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
Qianling Jiang, Jielin Duan, Luc Van Kaer, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model
Seong-Min Kim, Seung Hyuck Jeon, Min Guk Han, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13062-13062
Open Access | Times Cited: 4
Seong-Min Kim, Seung Hyuck Jeon, Min Guk Han, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13062-13062
Open Access | Times Cited: 4
Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients
Tianqi Zhang, Qiao Zhang, Xinwei He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3076-3076
Open Access | Times Cited: 1
Tianqi Zhang, Qiao Zhang, Xinwei He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3076-3076
Open Access | Times Cited: 1
Challenges of targeting tumor microenvironment in prostate cancer
Guoliang Li, Zhenbang Chen
IntechOpen eBooks (2024)
Open Access | Times Cited: 1
Guoliang Li, Zhenbang Chen
IntechOpen eBooks (2024)
Open Access | Times Cited: 1
Exploring combination therapy centered on targeted immunotherapy for advanced hepatocellular carcinoma: a beacon of hope
Y Wang, Yuqi Wu, Hong Zhang, et al.
Oncology and Translational Medicine (2024) Vol. 10, Iss. 6, pp. 292-299
Open Access | Times Cited: 1
Y Wang, Yuqi Wu, Hong Zhang, et al.
Oncology and Translational Medicine (2024) Vol. 10, Iss. 6, pp. 292-299
Open Access | Times Cited: 1
Myeloid-derived suppressor cells: Emerging players in cancer and beyond
Carlos Jiménez‐Cortegana, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xix
Closed Access | Times Cited: 3
Carlos Jiménez‐Cortegana, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xix
Closed Access | Times Cited: 3
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
Sergi Benavente
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 291-313
Open Access | Times Cited: 3
Sergi Benavente
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 291-313
Open Access | Times Cited: 3
BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model
Seong Min Kim, Seung Hyuck Jeon, Min Guk Han, et al.
(2023)
Open Access | Times Cited: 3
Seong Min Kim, Seung Hyuck Jeon, Min Guk Han, et al.
(2023)
Open Access | Times Cited: 3
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Filipa Lynce, Candace Mainor, Renee N. Donahue, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Filipa Lynce, Candace Mainor, Renee N. Donahue, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
NK cells direct the perspective approaches to cancer immunotherapy
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Farah A. Al-Marzook, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 2
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Farah A. Al-Marzook, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 2
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cells
John K. Wiencke, Emily Nissen, Devin C. Koestler, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
John K. Wiencke, Emily Nissen, Devin C. Koestler, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer
Morten F. Gjerstorff, Sofie Traynor, Odd L. Gammelgaard, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6153-6153
Open Access | Times Cited: 3
Morten F. Gjerstorff, Sofie Traynor, Odd L. Gammelgaard, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6153-6153
Open Access | Times Cited: 3
Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines
Carlos Jiménez‐Cortegana, Cristina Poveda, Gabriel Cabrera
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 1
Carlos Jiménez‐Cortegana, Cristina Poveda, Gabriel Cabrera
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 1
Dual impact of radiation therapy on tumor-targeting immune responses
Céline Mirjolet, Jérémy Baude, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xxiv
Closed Access | Times Cited: 1
Céline Mirjolet, Jérémy Baude, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xxiv
Closed Access | Times Cited: 1